AI News, Artificial Intelligence (AI) in Drug Discovery Market Worth $1,434 ... artificial intelligence

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical Biotechnology, CRO), Region - Global forecast to 2024

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, Immuno-Oncology, CVD), End User (Pharmaceutical & Biotechnology, CRO), Region - Global forecast to 2024“Growing number of cross-industry collaborations and partnerships and the need to control drug discovery & development costs and reduce the overall time taken in this process are the key factors driving the AI in the drug discovery market.”The global AI in the drug discovery market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8% during the forecast period.

On the other hand, a lack of data sets in the field of drug discovery and the inadequate availability of skilled labor are some of the factors challenging the growth of the market.“The immuno-oncology segment accounted for the largest share in 2019.”Based on application, the artificial intelligence in the drug discovery market is segmented into neurodegenerative diseases, immuno-oncology, cardiovascular disease, metabolic diseases, and other applications.

The ability of AI to discover drugs for complex diseases and the emphasis of market players on providing AI-based platforms for neurological diseases are responsible for the fast growth of this application segment.“The Research centers and academic & government institutes segment to register the highest growth rate in the forecast period.” Based on end-user, the AI in the drug discovery market is segmented into pharmaceutical & biotechnology companies, contract research organizations, and research centers and academic, & government institutes.

創薬の人工知能(AI)市場:ソフトウェア・サービス毎、技術毎、用途毎、エンドユーザ毎、地域毎 - 2024年までの世界市場予測

幅広い市場に関する調査レポートを出版しているマーケッツアンドマーケッツ(MarketsandMarkets)の創薬の人工知能(AI)市場に関する調査レポートです。 “Growing number of cross-industry collaborations and partnerships and the need to control drug discovery &

development costs and reduce the overall time taken in this process are the key factors driving the AI in the drug discovery market.”

The global AI in the drug discovery market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8% during the forecast period.

Growth in this market is mainly driven by growing number of cross-industry collaborations and partnerships, the need to control drug discovery &

development costs and reduce the overall time taken in this process, the rising adoption of cloud-based applications &

services, and the impending patent expiry of blockbuster drugs.

On the other hand, a lack of data sets in the field of drug discovery and the inadequate availability of skilled labor are some of the factors challenging the growth of the market. “The

immuno-oncology segment accounted for the largest share in 2019.”

Based on application, the artificial intelligence in the drug discovery market is segmented into neurodegenerative diseases, immuno-oncology, cardiovascular disease, metabolic diseases, and other applications.

The immuno-oncology segment accounted for the largest share of 44.6% of the AI in the drug discovery market in 2018, owing to the increasing demand for effective cancer drugs.

Neurodegenerative diseases form the fastest-growing application segment, with a CAGR of 42.9% during the forecast period.

The ability of AI to discover drugs for complex diseases and the emphasis of market players on providing AI-based platforms for neurological diseases are responsible for the fast growth of this application segment. “The

Research centers and academic &

government institutes segment to register the highest growth rate in the forecast period.” Based

on end-user, the AI in the drug discovery market is segmented into pharmaceutical &

biotechnology companies, contract research organizations, and research centers and academic, &

government institutes.

In 2018, the pharmaceutical &

biotechnology companies segment accounted for the largest share in the AI in the drug discovery market.

AI and machine learning to allow pharmaceutical companies to operate more efficiently and substantially improve success rates at the early stages of drug development.

This is one of the major factors driving the growth of this market.

Research centers and academic &

government institutes are expected to show the highest growth of 43.6%.during the forecast period.

The growth of the CROs segment is tied to that of pharmaceutical &

biotechnology companies, as the rise in research and production activity will ensure sustained demand for contract services. “North

America to be the largest and the fastest-growing regional market.” North

America, which comprises the US, Canada, and Mexico, forms the largest market for AI in drug discovery.

These countries have been early adopters of AI technology in drug discovery and development.

In the North American market, the US is a significant contributor.

Also, prominent AI technology providers, such as IBM, Google, Microsoft, NVIDIA, and Intel, are headquartered in the US;

their strong presence is a key contributor to market growth.

Other drivers include the well-established pharmaceutical industry, high focus on R&D &

substantial investment, and the presence of globally leading pharmaceutical companies.

These are some of the major factors responsible for the large share and high growth rate of this market. The

primary interviews conducted for this report can be categorized as follows: -

By Company Type: Tier 1 (28%), Tier 2 (42%), and Tier 3 (30%) -

By Designation: C-level (30%), D-level (34%), and Others (36%) -

By Region: North America (46%), Europe (25%), Asia (18%), and the RoW (11%) List

Berg LLC (US) Research Coverage: This report provides a study of the AI in the drug discovery market.

It aims at estimating the size and future growth potential of the market across different segments, such as offering, technology, application, end-user, and region.

The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies. Key

Benefits of Buying the Report: The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall AI in drug discovery market and its subsegments.

This report will also help stakeholders understand the competitive landscape, and gain insights to better position their business and make suitable go-to-market strategies.

It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.

1 INTRODUCTION 17 1.1

Key data from secondary sources 23 2.1.2

Key data from primary sources 24 2.1.2.2

Key industry insights 25 2.2

ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET, BY OFFERING (2019-2024) 36 4.3

REGION (2018) 37 4.4

Growing number of cross-industry collaborations and partnerships 40 5.2.1.2

Need to control drug discovery &

development costs and reduce time 41 5.2.1.3

Patent expiry 41 - 5.2.2

Growing biotechnology industry 42 5.2.2.2

Emerging markets 42 5.2.3

Limited availability of data sets 42 6

Strong economy and trend of early adoption of technologies are driving market growth in the US 86 10.2.1.2

Growing research on AI technologies and emergence of new AI-based start-ups will support the market in Canada 89 10.2.1.3

Government initiatives will support market growth in Mexico 91 10.3

The UK holds the largest share of the European market 95 10.3.2

Government support and favorable training programs are major market drivers in Germany 98 10.3.3

Strong government support and favorable strategies &

initiatives form key drivers of the market in France 99 10.3.4

Japan dominates the APAC market for AI in drug discovery 105 10.4.2

Growing CMOs market and cross-industry collaborations are factors responsible for the growth of the market in China 106 10.4.3

Steady adoption of AI technologies will drive market growth in India 108 10.4.4

Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies. - 13

AUTHOR DETAILS 155

1 INDICATIVE LIST OF COLLABORATIONS AND PARTNERSHIPS (2017-2019) 40 TABLE

2 INDICATIVE LIST OF DRUGS LOSING PATENT IN 2019 41 TABLE

5 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017-2024 (USD MILLION) 45 TABLE

6 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017-2024 (USD MILLION) 45 TABLE

7 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SOFTWARE, BY COUNTRY, 2017-2024 (USD MILLION) 46 TABLE

9 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2017-2024 (USD MILLION) 47 TABLE

10 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SERVICES, BY COUNTRY, 2017-2024 (USD MILLION) 47 TABLE

13 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY TYPE, 2017-2024 (USD MILLION) 50 TABLE

14 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY REGION, 2017-2024 (USD MILLION) 50 TABLE

15 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017-2024 (USD MILLION) 50 TABLE

16 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017-2024 (USD MILLION) 51 TABLE

17 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR MACHINE LEARNING, BY COUNTRY, 2017-2024 (USD MILLION) 51 TABLE

19 NORTH AMERICA: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017-2024 (USD MILLION) 52 TABLE

20 EUROPE: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017-2024 (USD MILLION) 53 TABLE

21 APAC: ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR DEEP LEARNING, BY COUNTRY, 2017-2024 (USD MILLION) 53 TABLE

22 ARTIFICIAL INTELLIGENCE IN DRUG DISCOVERY MARKET FOR SUPERVISED LEARNING, BY REGION, 2017-2024 (USD MILLION) 54 TABLE

150 OTHER STRATEGIES, 2016-2019 120

The global AI in the drug discovery market is projected to reach USD 1,434 million by 2024 from USD 259 million in 2019, at a CAGR of 40.8%

On the other hand, a lack of data sets in the field of drug discovery and the inadequate availability of skilled labor are some of the factors challenging the growth of the market.The immuno-oncology segment accounted for the largest share in 2019.Based on application, the artificial intelligence in the drug discovery market is segmented into neurodegenerative diseases, immuno-oncology, cardiovascular disease, metabolic diseases, and other applications.

biotechnology companies, as the rise in research and production activity will ensure sustained demand for contract services.North America to be the largest and the fastest-growing regional market.North America, which comprises the US, Canada, and Mexico, forms the largest market for AI in drug discovery.These countries have been early adopters of AI technology in drug discovery and development.In the North American market, the US is a significant contributor.Also, prominent AI technology providers, such as IBM, Google, Microsoft, NVIDIA, and Intel, are headquartered in the US;

(US)• XtalPi (US)• Verge Genomics (US)• Berg LLC (US)Research Coverage:This report provides a study of the AI in the drug discovery market.It aims at estimating the size and future growth potential of the market across different segments, such as offering, technology, application, end-user, and region.The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.Key Benefits of Buying the Report:The report will help market leaders/new entrants by providing them with the closest approximations of revenue numbers for the overall AI in drug discovery market and its subsegments.This report will also help stakeholders understand the competitive landscape, and gain insights to better position their business and make suitable go-to-market strategies.It will also enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, challenges, and opportunities.Read the full report: https://www.reportlinker.com/p05828730/?utm_source=PRN About Reportlinker ReportLinker is an award-winning market research solution.

Artificial Intelligence (AI) in Drug Discovery Market worth $1,434 million by 2024

Artificial Intelligence (AI) in Drug Discovery Market by Component (Software, Service), Technology (ML, DL), Application (Neurodegenerative Diseases, ...

CID - सी आई डी - Ep 1443 - Secret of the Eye - 15th July, 2017

Click here to Subscribe to SetIndia Channel : Click to watch all the episodes of CID ..